businesspress24.com - Paladin Labs to Present at the TD Securities 2012 Small Cap Conference in Toronto
 

Paladin Labs to Present at the TD Securities 2012 Small Cap Conference in Toronto

ID: 1161720

(firmenpresse) - MONTREAL, CANADA -- (Marketwire) -- 10/18/12 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, announced today that Ms. Samira Sakhia, Chief Financial Officer is scheduled to present a corporate update at the TD Securities 2012 Small Cap Conference on Thursday October 25, 2012 at 9:00 am ET at the St. Andrews Club and Conference Centre in Toronto. A copy of the presentation will be available at .

About Paladin Labs Inc.

Paladin Labs Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. With this strategy, a focused national sales team and proven marketing expertise, Paladin has evolved into one of Canada's leading specialty pharmaceutical companies. Paladin's shares trade on the Toronto Stock Exchange under the symbol PLB. For more information about Paladin, please visit the Company's web site at .

This press release may contain forward-looking statements and predictions. These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The Company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the Company and its subsidiaries, may ultimately prove to be incorrect. Factors and risks, which could cause actual results to differ materially from current expectations, are discussed in the annual report as well as in the Company's Annual Information Form for the year ended December 31, 2011. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information or future events and except as required by law. For additional information on risks and uncertainties relating to these forward-looking statements, investors should consult the Company's ongoing quarterly filings, annual report and Annual Information Form and other fillings found on SEDAR at .







Contacts:
Samira Sakhia, MBA, CA, CPA
Chief Financial Officer
Paladin Labs Inc.
Tel: 514-669-5367
514-344-4675 (FAX)
Email:
Website:


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Dr. Julia Liu to Present at American College of Gastroenterology Annual Meeting Oct 22, 2012
Paladin Announces Agreement for Novel OTC Product to Treat Cold Sores
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 18.10.2012 - 14:30 Uhr
Sprache: Deutsch
News-ID 1161720
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

MONTREAL, CANADA


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 103 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Paladin Labs to Present at the TD Securities 2012 Small Cap Conference in Toronto
"
steht unter der journalistisch-redaktionellen Verantwortung von

Paladin Labs Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Paladin Labs Inc.



 

Who is online

All members: 10 566
Register today: 1
Register yesterday: 0
Members online: 0
Guests online: 108


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.